Delivery Order SPE2DB22D2206-SPE2DB25FJB09
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $46,544 firm fixed-price delivery order on August 12, 2025, for the supply of GAMUNEX-C 40 gram/400 milliliter vials. The contract is unclassified as a set-aside and has an ultimate completion date of September 3, 2025. AmerisourceBergen will perform this delivery order from its corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a $13,963.20 delivery order to AmerisourceBergen Drug Corp for GAMUNEX-C 40 Gram/400 mL vials on August 15, 2025, with completion expected by September 8, 2025. This firm fixed-price contract represents a non-competitive set-aside delivery against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the contractor's location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order valued at $34,908.00 to AmerisourceBergen Drug Corp for the supply of GAMUNEX-C 40 gram/400 milliliter vials. The contract was competitively awarded on August 20, 2025, with a firm fixed price structure and an ultimate completion date of September 11, 2025. This non-set-aside delivery order will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $23,602.80 delivery order to AmerisourceBergen Drug Corp for GAMUNEX-C 20 gram/200 mL vials on September 4, 2025, with completion targeted for September 25, 2025. This firm fixed-price delivery order represents a non-competitive, non-set-aside procurement issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be...
- The Defense Logistics Agency awarded a $28,323.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of GAMUNEX-C 20 gram/200 mL vials. This non-set-aside competitive award is scheduled for completion by September 2, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,981.60 to AmerisourceBergen Drug Corp for GAMUNEX-C, a 40-gram/400 milliliter immunoglobulin vial. The contract, issued on August 6, 2025, carries a firm fixed price and is scheduled for completion by August 27, 2025. AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting the...
- The Defense Logistics Agency awarded a $23,272 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of GAMUNEX-C 40 gram/400 mL vials. This non-set-aside contract, which carries an ultimate completion date of August 20, 2025, is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The product will be delivered to...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of GAMUNEX-C 40 Gram/400 ML vials, with a ceiling value of $13,963.20. This firm fixed-price delivery order, which was competitively awarded without set-aside designation, is scheduled for ultimate completion on September 18, 2025. The product will be delivered to the company's location in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $55,852.80 to AmerisourceBergen Drug Corp for the supply of GAMUNEX-C 40 gram/400 mL vials. The contract is a firm fixed-price delivery order with an ultimate completion date of October 9, 2025, and was awarded on September 18, 2025. This award represents a non-set-aside competitive procurement, reflecting AmerisourceBergen's demonstrated capability to meet federal pharmaceutical supply requirements. The performance location...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for GAMUNEX-C 40 Gram/400 ML vials valued at $23,272.00 under a firm fixed price contract. The order, issued on April 24, 2025, is due for completion by May 15, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. This is an unset-aside competitive award, reflecting AmerisourceBergen's proven capability to meet federal procurement requirements through open competition. This...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJB09Delivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $34,908 on July 24, 2025, for the supply of GAMUNEX-C 40 gram/400 milliliter vials. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 14, 2025, with performance to take place at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a non-set-aside procurement, reflecting AmerisourceBergen's demonstrated capability to compete in the open federal pharmaceutical supply market. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a comprehensive global pharmaceutical supply vehicle valued at $999,999,999 through December 2026. The parent IDC enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications and medical commodities across multiple therapeutic domains. As a major pharmaceutical distributor serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, AmerisourceBergen maintains a significant position within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $34.9k | 7/24/25 |